Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects (Q40792736)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Thirunavukkarasu K

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Miles RR

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Halladay DL

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Yang X

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Galvin RJ

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Chandrasekhar S

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Martin TJ

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Onyia JE

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

12 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

276

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

36241-36250

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

A pitfall of using a second plasmid to determine transfection efficiency

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

TGF-beta receptors and signalling mechanisms

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104319200

21 January 2018

Identifiers

10.1074/JBC.M104319200

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40792736&oldid=1907413970"